L. Nguyen

发表

Short- and long-term biological variation of cardiac troponin I in healthy individuals, and patients with end-stage renal failure requiring haemodialysis or cardiomyopathy

S. Vasikaran, J. Rankin, N. Lan, 2020, Clinical chemistry and laboratory medicine.

Genetic analysis of familial hypercholesterolaemia in Western Australia.

G. Watts, F. V. van Bockxmeer, J. Burnett, 2012, Atherosclerosis.

Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy.

D. Allen, C. Semsarian, C. Bailey, 2006, Journal of molecular and cellular cardiology.

Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.

R. Weintraub, C. Semsarian, J. Ingles, 2005, Journal of molecular and cellular cardiology.

Pilot study of universal screening of children and child‐parent cascade testing for familial hypercholesterolaemia in Australia

G. Watts, J. Burnett, R. Norman, 2021, Journal of paediatrics and child health.

Genetic screening to improve the diagnosis of familial hypercholesterolemia

A. Hooper, L. Nguyen, F. M. Bockxmeer, 2014 .

Progression of left ventricular hypertrophy and the angiotensin-converting enzyme gene polymorphism in hypertrophic cardiomyopathy.

C. Semsarian, J. Ingles, L. Nguyen, 2004, International journal of cardiology.

Abnormal cardiac response to exercise in a murine model of familial hypertrophic cardiomyopathy.

C. Semsarian, L. Lam, T. Tsoutsman, 2007, International journal of cardiology.

Hypertrophic cardiomyopathy: from "heart tumour" to a complex molecular genetic disorder.

C. Semsarian, L. Nguyen, A. Doolan, 2004, Heart, lung & circulation.